NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
53 hedge funds and large institutions have $50.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
Holders
53
Holding in Top 10
–
Calls
$868K
Puts
$374K
Top Buyers
| 1 | +$964K | |
| 2 | +$942K | |
| 3 | +$364K | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$317K |
| 5 |
BIC
Beach Investment Counsel
West Conshohocken,
Pennsylvania
|
+$293K |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$477K | |
| 3 | -$421K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$88K |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$73.2K |